GlaxoSmithKline Pakistan Limited (PSX:GLAXO)

GlaxoSmithKline Pakistan Ratios and Metrics

Market cap in millions PKR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	125,951	126,403	26,430	27,952	43,474	61,092
Market Cap Growth	30.35%	378.26%	-5.45%	-35.70%	-28.84%	19.47%
Enterprise Value	119,311	119,878	22,631	20,591	38,013	57,102
Last Close Price	395.49	383.52	80.19	84.81	125.34	168.99
PE Ratio	13.71	19.34	49.50	11.35	8.12	18.10
PS Ratio	2.03	2.07	0.53	0.67	1.19	1.74
PB Ratio	4.24	4.47	1.22	1.33	2.07	3.50
P/TBV Ratio	4.38	4.63	1.28	1.39	2.17	3.71
P/FCF Ratio	28.77	55.38	112.68	-	11.80	13.15
P/OCF Ratio	17.64	24.99	14.03	-	8.72	10.25
EV/Sales Ratio	1.92	1.96	0.46	0.49	1.04	1.63
EV/EBITDA Ratio	7.35	10.57	7.85	3.48	4.98	10.09
EV/EBIT Ratio	8.00	11.69	11.52	4.06	5.53	11.63
EV/FCF Ratio	27.26	52.52	96.49	-	10.32	12.30
Debt / Equity Ratio	0.01	0.01	0.03	0.02	0.01	0.02
Debt / EBITDA Ratio	0.02	0.03	0.25	0.06	0.04	0.07
Debt / FCF Ratio	0.08	0.16	3.09	-	0.08	0.08
Asset Turnover	1.26	1.47	1.35	1.27	1.30	1.42
Inventory Turnover	2.40	3.95	4.30	4.20	4.24	4.48
Quick Ratio	0.84	1.17	0.83	0.92	1.41	1.13
Current Ratio	1.88	2.06	1.74	1.82	2.28	2.04
Return on Equity (ROE)	33.41%	26.17%	2.50%	11.72%	27.84%	20.08%
Return on Assets (ROA)	18.97%	15.40%	3.33%	9.60%	15.20%	12.45%
Return on Capital (ROIC)	33.59%	25.10%	5.61%	14.85%	21.96%	18.03%
Return on Capital Employed (ROCE)	46.90%	34.00%	8.30%	22.40%	31.10%	26.30%
Earnings Yield	7.29%	5.17%	2.02%	8.81%	12.32%	5.53%
FCF Yield	3.48%	1.81%	0.89%	-16.79%	8.47%	7.60%
Dividend Yield	2.50%	2.61%	-	-	5.58%	3.85%
Payout Ratio	51.61%	0.03%	345.56%	15.23%	38.51%	56.04%
Total Shareholder Return	2.50%	2.61%	-	-	5.58%	3.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.